Trial intelligence / Profile preview

SOLDIER: Hyperbaric Oxygen Therapy for Fracture-Related Infections

NCT07535164Phase 2Not yet recruiting

Sponsor
University of Amsterdam
Start
Aug 2026
Primary completion
Aug 2028
Modality
NPI (Non-Pharmacological Intervention)
Countries
1
01

Overview

A Phase 2 trial of hyperbaric oxygen therapy in fracture-related infection (FRI), sponsored by University of Amsterdam. Planned start Aug 2026; status: not yet recruiting.

02

Drugs

hyperbaric oxygen therapy
03

Conditions

fracture-related infection (FRI)

Beyond the preview

Go deeper on NCT07535164.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07535164.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call